Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bio-Technology General, Al-Kindi Pharmaceutical Industries, Teva sales and marketing update

BTGC and TEVA amended a 1999 agreement under which TEVA will begin marketing BTGC' s recombinant

Read the full 166 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE